Summary & Overview

CPT 20555: Interstitial Radioelement Application (Brachytherapy)

CPT code 20555 represents interstitial radioelement application, commonly known as brachytherapy, used to treat localized cancers such as prostate, cervix, and breast cancer. The procedure places radioactive seeds or sources directly into tumor tissue via implanted tubing or catheters, delivering high-dose radiation to the target while limiting exposure to surrounding healthy tissue. Nationally, this code is important for tracking utilization of specialized radiation oncology services and for aligning billing with clinical practice in oncology care.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, typical service locations, and the billing scope associated with CPT code 20555. The publication summarizes common modifiers associated with radiation therapy billing, highlights considerations for site-of-service coding, and outlines what to expect in payer coverage patterns at a national level. It also provides guidance on where to look for policy updates and reimbursement discussions relevant to interstitial brachytherapy.

This piece is intended for coding professionals, radiation oncology clinicians, and policy analysts seeking an authoritative snapshot of CPT code 20555, its clinical role, and its relevance to national payer coverage and billing practices.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare20555CPTbrachytherapyradiation-therapyinterstitial-applicationradiation-oncologyprocedure-codingoncology-billing

Billing Code Overview

CPT code 20555 describes interstitial radioelement application (brachytherapy), a targeted radiotherapy technique in which radioactive seeds are placed within or adjacent to tumor tissue. The procedure involves inserting small tubes into which radioactive seeds are placed either immediately or at a later encounter; the seeds emit localized radiation that damages or destroys cancer cells.

Service type: Radiation therapy — interstitial brachytherapy

Typical site of service: Hospital-based radiation oncology departments, freestanding radiation oncology centers, or ambulatory surgical centers, depending on clinical setting and institutional capability.

Clinical & Coding Specifications

Clinical Context

A 68-year-old male with intermediate-risk localized prostate adenocarcinoma is scheduled for interstitial brachytherapy. The radiation oncology team performs pre-procedure planning including transrectal ultrasound imaging, prostate volume assessment, and treatment planning to determine seed number and placement. On the day of service the patient receives conscious sedation; the clinician inserts hollow needles or applicator tubes through the perineum into the prostate under ultrasound guidance and places radioactive seeds (permanent low-dose-rate seeds) into the prostatic tissue. Post-implant imaging (CT or ultrasound) is obtained to verify seed placement and dosimetry. The typical site of service is an outpatient hospital or ambulatory surgery center within a radiation oncology department. The clinical workflow often involves a multidisciplinary team: urology for biopsy/sampling and referral, radiation oncology for planning and implant, medical physics for seed ordering and dosimetry, and nursing for peri-procedural care. Recovery includes short observation and outpatient follow-up for urinary, rectal, and sexual function monitoring.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the physician’s professional services separate from technical facility services when applicable (e.g., physician interpretation/planning billed separately).
`TC`	Technical component	Use when billing only the technical/facility portion of the procedure (equipment, staff, facility).
`52`	Reduced services	Use when the brachytherapy procedure is partially reduced or not completed as documented.
`53`	Discontinued procedure	Use when the procedure is started but terminated due to extenuating circumstances or complications.
`59`	Distinct procedural service	Use when another distinctly separate procedure is performed on the same day (note: `59` is not in the provided list; do not use).
`62`	Two surgeons	Use when two surgeons work together as primary surgeons on complex implant procedures that require two attending surgeons.
`63`	Procedure performed on infants less than 4 kg	Rarely applicable; would not typically apply to adult brachytherapy.
`66`	Surgical team (reporting multiple surgeons)	Use when a surgical team approach is documented for the implant.
`78`	Return to the operating room for a related procedure during the postoperative period	Use when an unplanned return to the OR is required for complications of the implant.
`79`	Unrelated procedure/by same physician during postoperative period	Use when an unrelated procedure is performed during global period (note: `79` is not in the provided list; do not use).
`80`	Assistant surgeon	Use when an assistant surgeon provides documented assistance during the implant.
`81`	Minimum assistant surgeon	Use when a documented minimum assistant involvement is provided.
`22`	Increased procedural services	Use when work required is substantially greater than typically required and documented.
`23`	Unusual anesthesia	Use when general anesthesia is medically necessary for a procedure usually performed with local or moderate sedation.

Taxonomy Code	Specialty	Notes
207RX0400X	Radiation Oncology	Primary specialty performing brachytherapy planning and implant.
208800000X	Radiation Therapy	Allied specialty/therapy services involved in delivery and planning.
2080P0207X	Medical Physics	Medical physicists handle dosimetry, seed activity calculation, and quality assurance.
208600000X	Urology	Urologists commonly involved for prostate seed implants and multidisciplinary care.
363L00000X	Surgical Oncology	Surgical oncologists may perform brachytherapy for select tumor sites.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C61`	Malignant neoplasm of prostate	Primary diagnosis for prostate interstitial brachytherapy; indicates localized prostate cancer targeted by seed implantation.
`C53.9`	Malignant neoplasm of cervix uteri, unspecified	Indication for intracavitary or interstitial brachytherapy in cervical cancer management.
`C50.919`	Malignant neoplasm of unspecified site of unspecified female breast	Breast-conserving therapy may include interstitial brachytherapy as a boost.
`C79.51`	Secondary malignant neoplasm of bone of pelvis and lower limb	Brachytherapy occasionally used for palliation of localized metastatic lesions, depending on site.
`D09.0`	Carcinoma in situ of cervix uteri	Early-stage cervical disease where brachytherapy may be part of definitive therapy.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`55873`	Brachytherapy, prostate, permanent implantation of radioactive seeds via transperineal placement, single or multiple implants	Common alternative/adjunct code for prostate permanent seed implantation; may be used depending on specific technique and device.
`77470`	Brachytherapy dose delivery, complex, requires physics package	Used for brachytherapy dose delivery and complex treatment planning/dosimetry associated with interstitial implants.
`51720`	Urethral catheterization, simple (eg, intermittent), includes insertion of guidewire, if performed	May be performed peri-procedurally for bladder management during prostate implants.
`77295`	Therapeutic radiology port film(s) for localization; simple (2-view)	Used for imaging localization or verification when required pre- or post-implant.
`77334`	Radiation therapy physics consult and treatment summary	Used for documentation of dosimetry review and physics consultation associated with brachytherapy planning.